J E Henningfield
Overview
Explore the profile of J E Henningfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
3360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heal D, Smith S, Belouin S, Henningfield J
Neuropharmacology
. 2023 May;
236:109610.
PMID: 37247807
This Special Issue of Neuropharmacology on psychedelics provides a timely and comprehensive update on progress following the previous Neuropharmacology Special Issue "Psychedelics: New Doors, Altered Perceptions". Remarkable advances have been...
2.
Ross S, Agrawal M, Griffiths R, Grob C, Berger A, Henningfield J
Neuropharmacology
. 2022 Jun;
216:109174.
PMID: 35772523
Psychiatric and existential distress commonly occur in advanced cancer and other serious, life-threatening or end-of-life medical illnesses and are associated with poor medical and psychiatric outcomes. Currently available treatment modalities...
3.
Henningfield J, Higgins S
Behav Anal
. 2012 Apr;
12(1):99-101.
PMID: 22478022
No abstract available.
4.
Henningfield J, Zaatari G
Tob Control
. 2010 Apr;
19(2):89-90.
PMID: 20378582
No abstract available.
5.
Wayne G, Connolly G, Henningfield J
Tob Control
. 2006 May;
15(3):189-98.
PMID: 16728749
The recent availability of internal tobacco industry documents provides significant insight into industry knowledge and manipulation of tobacco smoke delivery. One critical area of research is the role of smoke...
6.
Gray N, Henningfield J, Benowitz N, Connolly G, Dresler C, Fagerstrom K, et al.
Tob Control
. 2005 Jun;
14(3):161-5.
PMID: 15923465
Global tobacco deaths are high and rising. Tobacco use is primarily driven by nicotine addiction. Overall tobacco control policy is relatively well agreed upon but a long term nicotine policy...
7.
Henningfield J, Benowitz N, Connolly G, Davis R, Gray N, Myers M, et al.
Tob Control
. 2004 Jun;
13(2):132-5.
PMID: 15175528
Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction.
8.
Tomar S, Connolly G, Wilkenfeld J, Henningfield J
Tob Control
. 2003 Dec;
12(4):368-71.
PMID: 14660769
No abstract available.
9.
Henningfield J, Moolchan E, Zeller M
Tob Control
. 2003 May;
12 Suppl 1:i14-24.
PMID: 12773782
Preventing tobacco addiction and achieving cessation in established users are the cornerstones of efforts to reduce tobacco use and disease. It has been increasingly recognised that reducing tobacco toxin exposure...
10.
Garrett B, Rose C, Henningfield J
Expert Opin Pharmacother
. 2002 Feb;
2(10):1545-55.
PMID: 11825298
Even though its health consequences are well known, tobacco use continues to kill millions of smokers worldwide every year. In the US alone, tobacco use kills > 430,000 people each...